S 3635
Protecting Our Pharmaceutical Supply Chain from China Act of 2020
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the Protecting Our Pharmaceutical Supply Chain from China Act of 2020, aims to increase transparency and security in the U.S. drug supply. It requires the government to track the country of origin of drugs, prohibits federal health programs from purchasing drugs manufactured in China, and mandates that drugs be labeled with their country of origin. Additionally, the bill offers tax incentives to encourage domestic manufacturing of pharmaceuticals and medical devices.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Mike Braun
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.